\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ showed\\ sensory\\ deficits\\ including\\ sensation\\ to\\ \\ light\\ touch\\,\\ pinprick\\ \\,\\ vibration\\ and\\ proprioception\\,\\ in\\ the\\ left\\ and\\ right\\ legs\\ up\\ to\\ level\\ t2\\ and\\ t3\\.\\ motor\\ exam\\ revealed\\ hyporeflexia\\ in\\ the\\ right\\ leg\\ and\\ bilateral\\ babinski\\ signs\\.\ \(0\)\
\-\ patient\\ was\\ treated\\ with\\ azathioprine\\ and\\ steroids\\ with\\ near\\ complete\\ resolution\\ of\\ abnormal\\ imaging\\ findings\\.\\ \\ both\\ the\\ abnormal\\ cord\\ expansion\\ and\\ enhancement\\ have\\ largely\\ resolved\\.\ \(0\)\
\-\ there\\ is\\ a\\ large\\ lesion\\ involving\\ most\\ of\\ the\\ cervical\\ spinal\\ cord\\ and\\ \\ and\\ a\\ large\\ portion\\ of\\ the\\ thoracic\\ spinal\\ cord\\,\\ extending\\ from\\ c2\\ to\\ t9\\.\ \(0\)\
\-\ there\\ is\\ smooth\\ cord\\ expansion\\ with\\ mildly\\ decreased\\ signal\\ intensity\\ on\\ the\\ t1\\-weighted\\ images\\.\\ t2\\-weighted\\ images\\ demonstrate\\ increased\\ signal\\ intensity\\ and\\ cord\\ expansion\\.\\ the\\ lesion\\ involves\\ more\\ than\\ two\\ thirds\\ of\\ the\\ cross\\-sectional\\ area\\ of\\ the\\ cord\\.\\ \\ post\\-contrast\\ images\\ demonstrate\\ multiple\\ regions\\ of\\ patchy\\ and\\ nodular\\ enhancement\\.\\ there\\ is\\ also\\ evidence\\ of\\ focal\\ meningeal\\ enhancement\\.\\ \ \(0\)\
\-\ the\\ vertebrae\\ and\\ discs\\ are\\ not\\ involved\\.\ \(0\)\
\-\ transverse\\ myelitis\ \(14\)\
\-\ spinal\\ cord\\ neoplasm\\ \ \(0\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ cord\\ infarct\ \(3\)\
\-\ syringohydromyelia\ \(12\)\
\-\ neurosarcoid\ \(5\)\
\-\ 48\\ year\\ old\\ female\\ with\\ history\\ of\\ leg\\ weakness\\ and\\ loss\\ of\\ sensation\\ for\\ 3\\ weeks\\,\\ severe\\ ataxia\\ for\\ 3\\ days\\ and\\ increased\\ urination\\ for\\ 1\\-2\\ days\\.\\ past\\ medical\\ history\\ is\\ significant\\ for\\ hypertension\\ and\\ lupus\\ nephritis\\ diagnosed\\ in\\ 1987\\.\ \(0\)\
\-\ transverse\\ myelitis\\ is\\ not\\ a\\ single\\ diagnosis\\.\\ \\ what\\ is\\ most\\ important\\ is\\ to\\ image\\ the\\ spinal\\ cord\\ to\\ exclude\\ other\\ diseases\\ \\-\\ as\\ well\\ as\\ clinical\\ followup\\ demonstrating\\ resolution\\ of\\ signs\\ and\\ symptoms\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cord\\:\\ 0\\.11460613836019064\ \(0\)\
\-\ expansion\\:\\ 0\\.0495335086820989\ \(0\)\
\-\ spinal\\:\\ 0\\.04799648957458174\ \(0\)\
\-\ myelitis\\:\\ 0\\.046920039842433585\ \(0\)\
\-\ hyporeflexia\\:\\ 0\\.03457066048614313\ \(0\)\
\-\ 1987\\.\\:\\ 0\\.03457066048614313\ \(0\)\
\-\ sensation\\:\\ 0\\.0307856415352529\ \(0\)\
\-\ pinprick\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ vibration\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ urination\\:\\ 0\\.029134212011163167\ \(0\)\
\-\ resolution\\:\\ 0\\.02890682124739941\ \(0\)\
\-\ enhancement\\:\\ 0\\.02694692666027101\ \(0\)\
\-\ azathioprine\\:\\ 0\\.026939640293769353\ \(0\)\
\-\ transverse\\:\\ 0\\.026874091718823507\ \(0\)\
\-\ nephritis\\:\\ 0\\.026415987773673183\ \(0\)\
\-\ leg\\:\\ 0\\.026354488694970955\ \(0\)\
\-\ neurosarcoid\\:\\ 0\\.02595409351619717\ \(0\)\
\-\ cross\\-sectional\\:\\ 0\\.02554091502342138\ \(0\)\
\-\ thirds\\:\\ 0\\.025167149612424028\ \(0\)\
\-\ syringohydromyelia\\:\\ 0\\.025167149612424028\ \(0\)\
\-\ proprioception\\:\\ 0\\.024825928526190186\ \(0\)\
\-\ intensity\\:\\ 0\\.024224868050033734\ \(0\)\
\-\ t9\\:\\ 0\\.02422141605627937\ \(0\)\
\-\ babinski\\:\\ 0\\.023950855775938383\ \(0\)\
\-\ signs\\:\\ 0\\.0235872622273416\ \(0\)\
\-\ discs\\:\\ 0\\.022631356808796372\ \(0\)\
\-\ largely\\:\\ 0\\.021793811317431435\ \(0\)\
\-\ t3\\:\\ 0\\.02164581003122419\ \(0\)\
\-\ c2\\:\\ 0\\.02136557879992166\ \(0\)\
\-\ meningeal\\:\\ 0\\.02136557879992166\ \(0\)\
\-\ post\\-contrast\\:\\ 0\\.021104043997966088\ \(0\)\
\-\ days\\:\\ 0\\.02054175918566257\ \(0\)\
\-\ lupus\\:\\ 0\\.019730701137444066\ \(0\)\
\-\ vertebrae\\:\\ 0\\.019308620101395575\ \(0\)\
\-\ images\\:\\ 0\\.019285457552345342\ \(0\)\
\-\ 1\\-2\\:\\ 0\\.019229393798189616\ \(0\)\
\-\ abnormal\\:\\ 0\\.01911444894364636\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.018385819760476103\ \(0\)\
\-\ legs\\:\\ 0\\.018140641889961066\ \(0\)\
\-\ touch\\:\\ 0\\.018081669821864835\ \(0\)\
\-\ patchy\\:\\ 0\\.017966321252428388\ \(0\)\
\-\ ataxia\\:\\ 0\\.017909894831047605\ \(0\)\
\-\ exclude\\:\\ 0\\.017799420803727227\ \(0\)\
\-\ what\\:\\ 0\\.017691973846126776\ \(0\)\
\-\ signal\\:\\ 0\\.017671171217825715\ \(0\)\
\-\ sensory\\:\\ 0\\.017337526546251213\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.016968164918566113\ \(0\)\
\-\ diseases\\:\\ 0\\.01688101536254764\ \(0\)\
\-\ increased\\:\\ 0\\.016395959072938476\ \(0\)\
\-\ 48\\:\\ 0\\.016395252689164166\ \(0\)\
\-\ resolved\\:\\ 0\\.016245841527468986\ \(0\)\
\-\ followup\\:\\ 0\\.015997333237537267\ \(0\)\
\-\ steroids\\:\\ 0\\.01576363873870493\ \(0\)\
\-\ 3\\:\\ 0\\.015693925699659134\ \(0\)\
\-\ light\\:\\ 0\\.015636096810447832\ \(0\)\
\-\ involves\\:\\ 0\\.015573848382383949\ \(0\)\
\-\ most\\:\\ 0\\.015473216797867263\ \(0\)\
\-\ is\\:\\ 0\\.015435433132129722\ \(0\)\
\-\ demonstrate\\:\\ 0\\.015423154049670908\ \(0\)\
\-\ deficits\\:\\ 0\\.015334288805992425\ \(0\)\
\-\ regions\\:\\ 0\\.015334288805992425\ \(0\)\
\-\ important\\:\\ 0\\.015054057574689897\ \(0\)\
\-\ there\\:\\ 0\\.014961359487823397\ \(0\)\
\-\ infarct\\:\\ 0\\.014869168247530281\ \(0\)\
\-\ exam\\:\\ 0\\.014723403450584613\ \(0\)\
\-\ smooth\\:\\ 0\\.014668018073461455\ \(0\)\
\-\ large\\:\\ 0\\.014655234759459448\ \(0\)\
\-\ demonstrating\\:\\ 0\\.014547344902219284\ \(0\)\
\-\ near\\:\\ 0\\.014500096515881347\ \(0\)\
\-\ mildly\\:\\ 0\\.01427203408389282\ \(0\)\
\-\ multiple\\:\\ 0\\.014116125517484462\ \(0\)\
\-\ nodular\\:\\ 0\\.014056509047497692\ \(0\)\
\-\ involved\\:\\ 0\\.014056509047497692\ \(0\)\
\-\ motor\\:\\ 0\\.013994095497278479\ \(0\)\
\-\ lesion\\:\\ 0\\.013651413537258468\ \(0\)\
\-\ single\\:\\ 0\\.013582981531335026\ \(0\)\
\-\ hypertension\\:\\ 0\\.013210906087451717\ \(0\)\
\-\ thoracic\\:\\ 0\\.01291787257295785\ \(0\)\
\-\ weakness\\:\\ 0\\.01244553471775837\ \(0\)\
\-\ diagnosed\\:\\ 0\\.012322333948215707\ \(0\)\
\-\ cervical\\:\\ 0\\.012176829045457367\ \(0\)\
\-\ portion\\:\\ 0\\.012138065283761124\ \(0\)\
\-\ including\\:\\ 0\\.01209968094507029\ \(0\)\
\-\ sclerosis\\:\\ 0\\.012036530327162136\ \(0\)\
\-\ complete\\:\\ 0\\.0117936311136708\ \(0\)\
\-\ involving\\:\\ 0\\.011758459858836445\ \(0\)\
\-\ for\\:\\ 0\\.011436990566944551\ \(0\)\
\-\ neoplasm\\:\\ 0\\.011412378729066384\ \(0\)\
\-\ extending\\:\\ 0\\.011265564897410969\ \(0\)\
\-\ showed\\:\\ 0\\.010987463795779202\ \(0\)\
\-\ revealed\\:\\ 0\\.010754799568102326\ \(0\)\
\-\ past\\:\\ 0\\.010647841066456604\ \(0\)\
\-\ area\\:\\ 0\\.01059543625150693\ \(0\)\
\-\ and\\:\\ 0\\.010588765043071673\ \(0\)\
\-\ image\\:\\ 0\\.010467408495284708\ \(0\)\
\-\ severe\\:\\ 0\\.010311018823788251\ \(0\)\
\-\ medical\\:\\ 0\\.010311018823788251\ \(0\)\
\-\ clinical\\:\\ 0\\.010311018823788251\ \(0\)\
\-\ as\\:\\ 0\\.010137862791326493\ \(0\)\
\-\ treated\\:\\ 0\\.010030787592485723\ \(0\)\
\-\ decreased\\:\\ 0\\.009963750598919841\ \(0\)\
\-\ loss\\:\\ 0\\.00972731048026839\ \(0\)\
\-\ not\\:\\ 0\\.009684852327387729\ \(0\)\
\-\ level\\:\\ 0\\.009658388343713459\ \(0\)\
\-\ two\\:\\ 0\\.009597377402415709\ \(0\)\
\-\ focal\\:\\ 0\\.00957056315348393\ \(0\)\
\-\ weeks\\:\\ 0\\.009510893164318229\ \(0\)\
\-\ t2\\:\\ 0\\.009484661838236675\ \(0\)\
\-\ history\\:\\ 0\\.00925658460946732\ \(0\)\
\-\ up\\:\\ 0\\.009011165298251855\ \(0\)\
\-\ significant\\:\\ 0\\.009011165298251855\ \(0\)\
\-\ evidence\\:\\ 0\\.008786049346536776\ \(0\)\
\-\ than\\:\\ 0\\.008780583744777545\ \(0\)\
\-\ both\\:\\ 0\\.008557647022298515\ \(0\)\
\-\ more\\:\\ 0\\.008381083565930064\ \(0\)\
\-\ to\\:\\ 0\\.00837388447927424\ \(0\)\
\-\ symptoms\\:\\ 0\\.008351597948620153\ \(0\)\
\-\ physical\\:\\ 0\\.008221589292475445\ \(0\)\
\-\ bilateral\\:\\ 0\\.008132618546331153\ \(0\)\
\-\ imaging\\:\\ 0\\.007851269899825892\ \(0\)\
\-\ other\\:\\ 0\\.0077240727400096024\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007694977767766353\ \(0\)\
\-\ well\\:\\ 0\\.007580709619484906\ \(0\)\
\-\ have\\:\\ 0\\.007256619915157222\ \(0\)\
\-\ \\-\\:\\ 0\\.0071832488576798565\ \(0\)\
\-\ findings\\:\\ 0\\.007132693865842979\ \(0\)\
\-\ right\\:\\ 0\\.007071621247924836\ \(0\)\
\-\ female\\:\\ 0\\.006889255966462093\ \(0\)\
\-\ also\\:\\ 0\\.006606351347726084\ \(0\)\
\-\ the\\:\\ 0\\.005963694634274054\ \(0\)\
\-\ \\,\\:\\ 0\\.005308040500338968\ \(0\)\
\-\ from\\:\\ 0\\.004966414561389068\ \(0\)\
\-\ in\\:\\ 0\\.0049576144722382936\ \(0\)\
\-\ a\\:\\ 0\\.004665880021395309\ \(0\)\
\-\ of\\:\\ 0\\.004568776501881899\ \(0\)\
\-\ are\\:\\ 0\\.004568132833449419\ \(0\)\
\-\ was\\:\\ 0\\.0038755981263281837\ \(0\)\
\-\ left\\:\\ 0\\.003749432428521234\ \(0\)\
\-\ year\\:\\ 0\\.003749432428521234\ \(0\)\
\-\ old\\:\\ 0\\.0034311160661264885\ \(0\)\
\-\ patient\\:\\ 0\\.0033591840428093644\ \(0\)\
\-\ on\\:\\ 0\\.0028387882837859926\ \(0\)\
\-\ \\.\\:\\ 0\\.0019489941386778347\ \(0\)\
\-\ with\\:\\ 0\\.0018353596249394467\ \(0\)\
